Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc VRX. He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated GLW is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc SGYP for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.